Vaxcyte PCVX
NASDAQ PCVX
$61.11 -0.06 (-0.10%)
As of: Sep 4, 2026 · 2:31 PM EDT

Vaxcyte (PCVX) Net Shares Issued and Repurchased (2019 - 2023)

Analysis

Vaxcyte (PCVX) Net Shares Issued and Repurchased (2019 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn -
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn -
5 Revolution Medicines 44.07 Bn 44.07 Bn - -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn -
10 Vaxcyte 8.83 Bn 8.83 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 44,537.00
Mar 31, 2023 36,710.00
Dec 31, 2022 45,052.00
Mar 31, 2022 62,382.00
Dec 31, 2021 1.62 Mn
Mar 31, 2021 66,982.00
Dec 31, 2020 62,382.00
Dec 31, 2019 887,659.00